{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T17:34:38Z","timestamp":1782236078575,"version":"3.54.5"},"reference-count":17,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T00:00:00Z","timestamp":1592870400000},"content-version":"unspecified","delay-in-days":22,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Boehringer Ingelheim Norway KS"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Resp Res"],"accepted":{"date-parts":[[2020,5,28]]},"published-print":{"date-parts":[[2020,6]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Idiopathic pulmonary fibrosis (IPF) and systemic sclerosis-associated interstitial lung disease (SSc-ILD) are fibrotic ILDs with divergent disease populations. Little is known about health-related quality of life (HRQL) in SSc-ILD relative to IPF.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We used the Kings Brief Interstitial Lung Disease Questionnaire (K-BILD) to compare HRQL in a cross-sectional study of 57 patients with IPF and 29 patients with SSc-ILD. Analysis of covariance was used to adjust for age, gender and lung function.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The unadjusted mean K-BILD score was 63.1 (95% CI 57.1 to 69.1) among patients with SSc-ILD, as compared with 54.7 (51.8\u201357.5) among those with IPF (p=0.005). However, this difference in HRQL was attenuated after adjustment for age, gender and lung function. In a multivariable model, only forced vital capacity was associated with K-BILD scores. K-BILD scores were correlated with both forced vital capacity and with other relevant HRQL measures, regardless of ILD diagnosis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Discussion<\/jats:title>\n                  <jats:p>Patients with SSc-ILD may have better ILD-specific quality of life than patients with IPF, but this difference appears to be driven primarily by better lung function. These results underscore the impact of lung function on HRQL in fibrotic ILD and the utility of K-BILD to assess HRQL in SSc-ILD.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjresp-2020-000598","type":"journal-article","created":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T02:25:38Z","timestamp":1592965538000},"page":"e000598","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":17,"title":["ILD-specific health-related quality of life in systemic sclerosis-associated ILD compared with IPF"],"prefix":"10.1136","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4186-5698","authenticated-orcid":false,"given":"Michael T","family":"Durheim","sequence":"first","affiliation":[{"name":"Institute for Clinical Medicine, University of Oslo, Oslo, Norway"},{"name":"Department of Respiratory Medicine, Oslo University Hospital - Rikshospitalet, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Maria","family":"Hoffmann-Vold","sequence":"additional","affiliation":[{"name":"Institute for Clinical Medicine, University of Oslo, Oslo, Norway"},{"name":"Department of Rheumatology, Oslo University Hospital - Rikshospitalet, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas M","family":"Eagan","sequence":"additional","affiliation":[{"name":"Department of Thoracic Medicine, Haukeland University Hospital, Bergen, Norway"},{"name":"Department of Clinical Science, University of Bergen, Bergen, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnt-Ove","family":"Hovden","sequence":"additional","affiliation":[{"name":"Boehringer Ingelheim Norway KS, Asker, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May Brit","family":"Lund","sequence":"additional","affiliation":[{"name":"Institute for Clinical Medicine, University of Oslo, Oslo, Norway"},{"name":"Department of Respiratory Medicine, Oslo University Hospital - Rikshospitalet, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisle","family":"Bjerke","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, Akershus University Hospital, Lorenskog, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surinder S","family":"Birring","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, King's College Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trygve M","family":"Jonassen","sequence":"additional","affiliation":[{"name":"Department of Thoracic Medicine, Haukeland University Hospital, Bergen, Norway"},{"name":"Department of Clinical Science, University of Bergen, Bergen, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odd Erik","family":"Johansen","sequence":"additional","affiliation":[{"name":"Boehringer Ingelheim Norway KS, Asker, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tone","family":"Sj\u00e5heim","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Oslo University Hospital - Rikshospitalet, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,6,23]]},"reference":[{"key":"2025083112190686000_7.1.e000598.1","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-017-0621-y","article-title":"Health related quality of life in patients with idiopathic pulmonary fibrosis in clinical practice: insights-IPF registry","volume":"18","author":"Kreuter","year":"2017","journal-title":"Respir Res"},{"key":"2025083112190686000_7.1.e000598.2","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2004.035220"},{"key":"2025083112190686000_7.1.e000598.3","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00692-2018","article-title":"What's in a name? that which we call IPF, by any other name would act the same","volume":"51","author":"Wells","year":"2018","journal-title":"Eur Respir J"},{"key":"2025083112190686000_7.1.e000598.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1903076"},{"key":"2025083112190686000_7.1.e000598.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908681"},{"key":"2025083112190686000_7.1.e000598.6","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S2213-2600(19)30341-8","article-title":"Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial","volume":"8","author":"Maher","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2025083112190686000_7.1.e000598.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30933-9"},{"key":"2025083112190686000_7.1.e000598.8","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1164\/rccm.201903-0486OC","article-title":"Tracking impact of interstitial lung disease in systemic sclerosis in a complete nationwide cohort","volume":"200","author":"Hoffmann-Vold","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2025083112190686000_7.1.e000598.9","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.semarthrit.2016.02.005","article-title":"Impaired quality of life in systemic sclerosis and patient perception of the disease: a large international survey","volume":"46","author":"Frantz","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"2025083112190686000_7.1.e000598.10","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2012-201581"},{"key":"2025083112190686000_7.1.e000598.11","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.2009-040GL"},{"key":"2025083112190686000_7.1.e000598.12","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204424"},{"key":"2025083112190686000_7.1.e000598.13","doi-asserted-by":"publisher","DOI":"10.1016\/S0954-6111(06)80166-6"},{"key":"2025083112190686000_7.1.e000598.14","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.58.4.339"},{"key":"2025083112190686000_7.1.e000598.15","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-011-9903-x"},{"key":"2025083112190686000_7.1.e000598.16","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2018-000363"},{"key":"2025083112190686000_7.1.e000598.17","doi-asserted-by":"crossref","first-page":"31090","DOI":"10.3402\/ecrj.v3.31090","article-title":"Idiopathic pulmonary fibrosis in Sweden: report from the first year of activity of the Swedish IPF-Registry","volume":"3","author":"Ferrara","year":"2016","journal-title":"Eur Clin Respir J"}],"container-title":["BMJ Open Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjresp-2020-000598","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T19:19:15Z","timestamp":1756667955000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopenrespres.bmj.com\/lookup\/doi\/10.1136\/bmjresp-2020-000598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,6,23]]},"published-print":{"date-parts":[[2020,6]]}},"alternative-id":["10.1136\/bmjresp-2020-000598"],"URL":"https:\/\/doi.org\/10.1136\/bmjresp-2020-000598","relation":{},"ISSN":["2052-4439"],"issn-type":[{"value":"2052-4439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6]]}}}